Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies

Creasy, John; Goldman, Debra; Gonen, Mithat; Dudeja, Vikas; Askan, GÖKÇE; Basturk, Olca; Balachandran, Vinod; Allen, Peter; DeMatteo, Ronald; D'Angelica, Michael; Jarnagin, William; Kingham, T.

doi:10.1007/s11605-017-3436-8

Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies

Creasy J. M., Goldman D. A., Gonen M., Dudeja V., Askan G., Basturk O., ...Daha Fazla

JOURNAL OF GASTROINTESTINAL SURGERY, cilt.21, sa.8, ss.1254-1261, 2017 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 8
Basım Tarihi: 2017
Doi Numarası: 10.1007/s11605-017-3436-8
Dergi Adı: JOURNAL OF GASTROINTESTINAL SURGERY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1254-1261
Anahtar Kelimeler: Incidental gallbladder carcinoma, GBCA, Residual disease, RESECTION, CARCINOMA, ADENOCARCINOMA
İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Introduction Re-operation is advised for patients with T1b or greater incidental gallbladder cancer (GBCA). The presence of residual disease (RD) impacts resectability, chemotherapy, and survival. This study created a preoperative model to predict RD at re-operation.